Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

Completed · Phase 1

Conditions studied: Bacterial Infections

In brief

A study of the safety and pharmacokinetics of solithromycin capsules in adolescents

Key facts

Study ID

NCT01966055

Run by

Melinta Therapeutics, Inc.

People needed

13

Starts

2013-12-01

Expected to finish

2014-09-01

Last updated by the study team

2017-02-23

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 12 to 17 yo male or female with suspected or confirmed bacterial infection

You may not qualify if…

• Bacterial meningitis
• Clinical significant concomitant medical condition

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — San Diego, California, United States
• Study site — Chicago, Illinois, United States
• Study site — Louisville, Kentucky, United States
• Study site — Ann Arbor, Michigan, United States
• Study site — Hackensack, New Jersey, United States
• Study site — New York, New York, United States
• Study site — Portland, Oregon, United States
• Study site — Hershey, Pennsylvania, United States
• Study site — Galveston, Texas, United States
• Study site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.